NCT02852473

Brief Summary

This study involves a breathing motion assessment in healthy subjects before and after continuous positive airway pressure (CPAP) administration using MRI images. The hypothesis for this study is that CPAP administration will significantly reduce breathing motion. This may help cancer patients who are undergoing proton radiotherapy, so they possibly will not have to hold their breath during the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at P25-P50 for early_phase_1 cancer

Timeline
Completed

Started Jul 2016

Shorter than P25 for early_phase_1 cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2016

Completed
28 days until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 2, 2016

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

October 14, 2016

Status Verified

October 1, 2016

Enrollment Period

2 months

First QC Date

June 3, 2016

Last Update Submit

October 13, 2016

Conditions

Keywords

Continuous Positive Airway PressureRadiotherapyProton Therapy

Outcome Measures

Primary Outcomes (1)

  • Change in Breathing Motion Characteristics at High CPAP Setting

    Breathing motion at baseline and at initial (higher but tolerable) CPAP settings will be characterized using fast multi-slice, multi-phase 2D gradient-echo or spin-echo MRI sequences in the sagittal or coronal imaging planes over a large field of view covering the thoracic and upper-abdominal region. Specifically "4D-MRI" (or time-resolved MRI) will be generated from retrospective sorting of multi-slice 2D MRI. For these analyses, anatomic reference points (e.g., bright vessels) in multiple organ systems will be identified on the images, contoured or segmented; subsequently 3D motion patterns will be extracted for all anatomical references/features. Numerical simulations will be performed to determine hypothetical radiation target volume changes (cm\^3) at these anatomic locations assuming spherical tumors with a given set of tumor diameters (cm).

    Data acquisition for this portion of the study will require approximately 30 minutes.

Secondary Outcomes (1)

  • Change in Breathing Motion Characteristics at Lower CPAP Setting

    Approximately 45 minutes into visit.

Study Arms (1)

Continuous Positive Airway Pressure

EXPERIMENTAL

Continuous Positive Airway Pressure (CPAP) will be administered using FDA-approved equipment.

Other: Continuous Positive Airway Pressure

Interventions

CPAP requires subjects to wear a plastic pressurized mask/apparatus, which is connected via a filter and hose to a pump capable of supplying variable pressure (typically on the range of 4-20 cm H2O). The investigators plan to use a full-face mask to prevent subjects from reducing pressure by opening their mouths. If this cannot be tolerated or properly fitted, or is not compatible with the CPAP ventilator, subjects would use a nasal mask only and be asked to keep their mouths closed.

Continuous Positive Airway Pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adult female and males
  • Subject meets routine MRI safety criteria

You may not qualify if:

  • Age \<18
  • Known history of chronic obstructive pulmonary disease (COPD), asthma, or other chronic pulmonary illness
  • Pregnancy
  • Any safety risk identified via MRI safety screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Continuous Positive Airway Pressure

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Erik J Tryggestad, PhD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medical Physics

Study Record Dates

First Submitted

June 3, 2016

First Posted

August 2, 2016

Study Start

July 1, 2016

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

October 14, 2016

Record last verified: 2016-10

Locations